Evidence map›Paper›PMID 35792534›Full record

ReviewJournal of microscopy2022

Towards super-resolved terahertz microscopy for cellular imaging.

Rocco D'Antuono, John W Bowen

Open access · hybridAbstract readReview
In one paragraph

Review in Journal of microscopy, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
1.1field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Rocco D'AntuonoCrick Advanced Light Microscopy STP, The Francis Crick Institute, 1 Midland Road, NW1 1AT, London, UK.ORCID 0000-0003-0180-6500
John W BowenDepartment of Biomedical Engineering, School of Biological Sciences, University of Reading, Reading, UK.ORCID 0000-0003-2590-3399
The Francis Crick Institute · GBUniversity of Reading · GB

Funding

Cancer Research UK FC001999Medical Research Council FC001999Wellcome Trust FC001999
6 · The paper itself

Abstract

Biomedical imaging includes the use of a variety of techniques to study organs and tissues. Some of the possible imaging modalities are more spread at clinical level (CT, MRI, PET), while others, such as light and electron microscopy are preferred in life sciences research. The choice of the imaging modalities can be based on the capability to study functional aspects of an organism, the delivered radiation dose to the patient, and the achievable resolution. In the last few decades, spectroscopists and imaging scientists have been interested in the use of terahertz (THz) frequencies (30 μm to 3 mm wavelength) due to the low photon energy associated (E∼1 meV, not causing breaking of the molecular bonds but still interacting with some vibrational modes) and the high penetration depth that is achievable. THz has been already adopted in security, quality control and material sciences. However, the adoption of THz frequencies for biological and clinical imaging means to face, as a major limitation, the very scarce resolution associated with the use of such long wavelengths. To address this aspect and reconcile the benefit of minimal harmfulness for bioimaging with the achievable resolving power, many attempts have been made. This review summarises the state-of-the-art of THz imaging applications aimed at achieving super-resolution, describing how practical aspects of optics and quasi-optics may be treated to efficaciously implement the use of THz as a new low-dose and versatile modality in biomedical imaging and clinical research.

Indexed as

MicroscopyTerahertz ImagingHumanscellulardeconvolutionimagingmicroscopysuper-resolutionterahertz

Identifiers

PMID35792534
PMCPMC10084438
OpenAlexW4284703742

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.